Displaying 701 - 710 of 1642
For far too long, families have face unaffordable medical costs due to “surprise billing.” Surprise billing, also called surprise out-of-network balance billing, is a common problem when, through no fault of their own, families…
Families USA filed an amicus brief in the Texas v. US case that threatens the entire Affordable Care Act, on appeal in the US Court of Appeals of the Fifth Circuit. Cosigners of the amicus include…
Kansas lawmakers are currently considering legislation that could expand Medicaid to 150,000 nonelderly, low-income Kansans. As lawmakers debate Medicaid expansion in the state’s legislature, Families USA has published a fact sheet on the impact…
On May 16th, the Centers for Medicare and Medicaid Services announced a final regulation for Medicare’s Part D drug benefit for 2020. The regulation backed off of a proposal that would have created significant exceptions to…
Federal Judge Boasberg struck down work requirements for the Medicaid program in both Arkansas and Kentucky. This March 28th webinar discussed the Judge's ruling and what it means for the future of Medicaid. Featured…
Key findings On March 26, 2019, the chairs of three House committees with jurisdiction over core health care issues—Education and Labor, Energy and Commerce, and Ways and Means—jointly introduced legislation that would lower health…
Oral health is an important aspect of overall health and influences physical and mental well-being, but receives less of its fair share of attention and resources. For people with mental health conditions and substance…
State health plans for families are under scrutiny – in the courts, in the states, and in Washington. It is hard to think of a time when the Medicaid program was getting so much…
From Trump administration block grant proposals, to work requirements in the federal courts, to the waiver restrictions faced in the Capitol hallways of West Virginia; Medicaid waivers are under scrutiny. Speakers examine what's happening…
Eight in ten Americans say the cost of prescription drugs is “unreasonable.” This is a problem driven by high launch prices and price increases, which are rooted in drug corporations’ monopoly power and perverse incentives…